CY1110972T1 - Ανοσοκαταστολη με σαπερονινη 10 - Google Patents
Ανοσοκαταστολη με σαπερονινη 10Info
- Publication number
- CY1110972T1 CY1110972T1 CY20101101115T CY101101115T CY1110972T1 CY 1110972 T1 CY1110972 T1 CY 1110972T1 CY 20101101115 T CY20101101115 T CY 20101101115T CY 101101115 T CY101101115 T CY 101101115T CY 1110972 T1 CY1110972 T1 CY 1110972T1
- Authority
- CY
- Cyprus
- Prior art keywords
- donor
- recipient animal
- saperonin
- immune
- cpn10
- Prior art date
Links
- 208000009329 Graft vs Host Disease Diseases 0.000 abstract 2
- 208000024908 graft versus host disease Diseases 0.000 abstract 2
- 101150006844 groES gene Proteins 0.000 abstract 2
- 238000000034 method Methods 0.000 abstract 2
- 229940125721 immunosuppressive agent Drugs 0.000 abstract 1
- 239000003018 immunosuppressive agent Substances 0.000 abstract 1
- 210000000056 organ Anatomy 0.000 abstract 1
- 230000002265 prevention Effects 0.000 abstract 1
- 238000002054 transplantation Methods 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Marine Sciences & Fisheries (AREA)
- Transplantation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Glass Compositions (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| AU2002952492A AU2002952492A0 (en) | 2002-11-06 | 2002-11-06 | Chaperonin 10 immunosuppression |
| EP03769073A EP1569679B1 (en) | 2002-11-06 | 2003-11-06 | Chaperonin 10 immunosuppression |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CY1110972T1 true CY1110972T1 (el) | 2015-06-11 |
Family
ID=28795882
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CY20101101115T CY1110972T1 (el) | 2002-11-06 | 2010-12-03 | Ανοσοκαταστολη με σαπερονινη 10 |
Country Status (16)
| Country | Link |
|---|---|
| US (3) | US7618935B2 (enExample) |
| EP (3) | EP2255824B1 (enExample) |
| JP (2) | JP4716731B2 (enExample) |
| KR (1) | KR101088740B1 (enExample) |
| CN (1) | CN100525832C (enExample) |
| AT (1) | ATE489963T1 (enExample) |
| AU (1) | AU2002952492A0 (enExample) |
| CA (1) | CA2505141C (enExample) |
| CY (1) | CY1110972T1 (enExample) |
| DE (1) | DE60335202D1 (enExample) |
| DK (1) | DK1569679T3 (enExample) |
| ES (1) | ES2351993T3 (enExample) |
| NZ (1) | NZ540433A (enExample) |
| PT (1) | PT1569679E (enExample) |
| SI (1) | SI1569679T1 (enExample) |
| WO (1) | WO2004041300A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2007517808A (ja) | 2004-01-16 | 2007-07-05 | キュビオ リミテッド | Ｔｏｌｌ様受容体誘導性のサイトカインおよびケモカイン分泌のシャペロニン１０調節 |
| AU2005204979B2 (en) * | 2004-01-16 | 2010-10-21 | Cbio Limited | Chaperonin 10 modulation of toll-like receptor-inducible cytokine and chemokine secretion |
| US8036710B2 (en) * | 2004-05-07 | 2011-10-11 | Qualcomm, Incorporated | Power-efficient multi-antenna wireless device |
| AU2006269824B2 (en) * | 2005-07-11 | 2012-04-19 | Cbio Limited | Chaperonin 10-induced immunomodulation |
| EP1906989A4 (en) | 2005-07-11 | 2009-08-19 | Cbio Ltd | IMMUNOMODULATION INDUCED BY CHAPERONIN 10 |
| EP2463307A1 (en) | 2005-08-31 | 2012-06-13 | CBIO Limited | Modified chaperonin 10 |
| AU2006303826B2 (en) * | 2005-10-20 | 2012-07-19 | Cbio Limited | Treatment of hypersensitivity |
| CA2626692A1 (en) * | 2005-10-20 | 2007-04-26 | Cbio Limited | Treatment of hypersensitivity |
| MX2008011167A (es) | 2006-03-02 | 2008-11-12 | Cbio Ltd | Regulaciòn de respuestas inmunes mediante la modulaciòn de la funciòn de cèlulas presentadoras de antìgenos. |
| CA2720617A1 (en) * | 2008-04-11 | 2009-10-15 | Cbio Limited | Modified cpn10 and prr signalling |
| US20110243921A1 (en) * | 2010-03-30 | 2011-10-06 | Cbio Limited | Prevention and treatment of cutaneous lupus erythematosus |
| WO2013158959A1 (en) * | 2012-04-19 | 2013-10-24 | Tarix Pharmaceuticals Ltd. | Compositions and methods for treatment of graft-versus-host disease |
| WO2014063194A1 (en) | 2012-10-23 | 2014-05-01 | The University Of Sydney | Elastic hydrogel |
| US10842913B2 (en) | 2012-12-10 | 2020-11-24 | Allergan Pharmaceuticals International Limited | Scalable three-dimensional elastic construct manufacturing |
| RU2677637C2 (ru) | 2013-08-13 | 2019-01-18 | Эластаджен Пти Лтд | Регенерация поврежденной ткани |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2176948C (en) * | 1993-11-30 | 2007-05-15 | Halle Morton | Chaperonin 10 |
| WO1995015338A1 (en) | 1993-11-30 | 1995-06-08 | The University Of Queensland | Chaperonin 10 |
| US5989804A (en) * | 1994-07-08 | 1999-11-23 | New England Medical Center Hospitals, Inc. | E6 binding proteins |
| EP0845994A1 (en) * | 1995-08-09 | 1998-06-10 | Schering Corporation | Combined use of interleukin-10 and cyclosporin for immunosuppression therapy |
| US20020142000A1 (en) * | 1999-01-15 | 2002-10-03 | Digan Mary Ellen | Anti-CD3 immunotoxins and therapeutic uses therefor |
| EP1218030A4 (en) | 1999-09-10 | 2004-09-15 | Univ Fordham | METHODS AND COMPOSITIONS FOR TREATING AND PREVENTING TRANSPLANT REJECTION BY USING HEAT SHOCK PROTEINS |
| GB0028122D0 (en) * | 2000-11-17 | 2001-01-03 | St Georges Entpr Ltd | Method |
-
2002
- 2002-11-06 AU AU2002952492A patent/AU2002952492A0/en not_active Abandoned
-
2003
- 2003-11-06 CN CNB2003801082969A patent/CN100525832C/zh not_active Expired - Fee Related
- 2003-11-06 EP EP10174226.0A patent/EP2255824B1/en not_active Expired - Lifetime
- 2003-11-06 EP EP14177983.5A patent/EP2818179A1/en not_active Withdrawn
- 2003-11-06 WO PCT/AU2003/001467 patent/WO2004041300A1/en not_active Ceased
- 2003-11-06 NZ NZ540433A patent/NZ540433A/en not_active IP Right Cessation
- 2003-11-06 CA CA2505141A patent/CA2505141C/en not_active Expired - Fee Related
- 2003-11-06 ES ES03769073T patent/ES2351993T3/es not_active Expired - Lifetime
- 2003-11-06 PT PT03769073T patent/PT1569679E/pt unknown
- 2003-11-06 JP JP2004548934A patent/JP4716731B2/ja not_active Expired - Fee Related
- 2003-11-06 AT AT03769073T patent/ATE489963T1/de active
- 2003-11-06 SI SI200331912T patent/SI1569679T1/sl unknown
- 2003-11-06 DE DE60335202T patent/DE60335202D1/de not_active Expired - Lifetime
- 2003-11-06 DK DK03769073.2T patent/DK1569679T3/da active
- 2003-11-06 KR KR1020057008096A patent/KR101088740B1/ko not_active Expired - Fee Related
- 2003-11-06 EP EP03769073A patent/EP1569679B1/en not_active Expired - Lifetime
- 2003-11-06 US US10/534,193 patent/US7618935B2/en not_active Expired - Fee Related
-
2009
- 2009-10-01 US US12/572,195 patent/US8067361B2/en not_active Expired - Fee Related
-
2010
- 2010-12-03 CY CY20101101115T patent/CY1110972T1/el unknown
- 2010-12-22 JP JP2010286005A patent/JP2011088920A/ja active Pending
-
2011
- 2011-11-07 US US13/290,996 patent/US20120082690A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| CN1735428A (zh) | 2006-02-15 |
| US20120082690A1 (en) | 2012-04-05 |
| EP1569679A4 (en) | 2008-02-27 |
| EP2255824B1 (en) | 2014-07-23 |
| EP1569679B1 (en) | 2010-12-01 |
| DK1569679T3 (da) | 2011-01-10 |
| JP4716731B2 (ja) | 2011-07-06 |
| AU2002952492A0 (en) | 2002-11-21 |
| EP2255824A1 (en) | 2010-12-01 |
| ES2351993T3 (es) | 2011-02-14 |
| US7618935B2 (en) | 2009-11-17 |
| SI1569679T1 (sl) | 2011-01-31 |
| KR101088740B1 (ko) | 2011-12-01 |
| CA2505141A1 (en) | 2004-05-21 |
| WO2004041300A1 (en) | 2004-05-21 |
| PT1569679E (pt) | 2010-12-14 |
| ATE489963T1 (de) | 2010-12-15 |
| EP2818179A1 (en) | 2014-12-31 |
| US8067361B2 (en) | 2011-11-29 |
| US20060198834A1 (en) | 2006-09-07 |
| NZ540433A (en) | 2008-03-28 |
| KR20050086428A (ko) | 2005-08-30 |
| DE60335202D1 (en) | 2011-01-13 |
| US20100099605A1 (en) | 2010-04-22 |
| CN100525832C (zh) | 2009-08-12 |
| CA2505141C (en) | 2012-07-17 |
| JP2006508099A (ja) | 2006-03-09 |
| EP1569679A1 (en) | 2005-09-07 |
| JP2011088920A (ja) | 2011-05-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE60335202D1 (en) | Chaperonin-10-immunosuppression | |
| BR0203650A (pt) | Estentor de auto-articulação | |
| DK1487431T3 (da) | Forebyggelse og/eller behandling af cardiovaskulær sygdom og/eller dermed associeret hjertefejl | |
| ES2114888T3 (es) | Tratamiento contra el rechazo en el transplante de organos. | |
| CO5700767A2 (es) | Procedimiento de tratamiento de rechazo de transplantes | |
| ECSP105739A (es) | Anticuerpos de neutralización contra gdf-8 | |
| ATE400577T1 (de) | Anellierte dihydropyrane | |
| DE60330468D1 (de) | Schweine ohne jegliche expression funktioneller alpha-1,3-galactosyltransferase | |
| YU97402A (sh) | Koštana (transkutalna) proteza | |
| ATE423577T1 (de) | Biologisch modellierte implantierbare prothesen | |
| WO2004031129A3 (en) | Compounds for use in the treatment of autoimmune diseases, immuno-allergical diseases and organ or tissue transplantation rejection | |
| DE69833937D1 (de) | Verwendung von zinkhyaluronat gegen magengeschwür | |
| BR9612821A (pt) | Métodos para a prevenção de rejeição de enxerto em transplante e para a produção de uma célula de hospedeiro para terapia genética universal | |
| DK1567171T3 (da) | Anvendelse af dextransulfat til behandling af ibmir | |
| DE3875306D1 (de) | Immunosuppression bei der auf immunotoxin basierten behandlung von menschen. | |
| WO2005041877A3 (en) | Method of inhibiting rejection following organ transplantation | |
| DE69727948D1 (de) | Sordarinderivate | |
| YU58600A (sh) | Oblik vi 5,6-dihloro-2-(izopropilamino)-1-(beta-l-ribofuranozil)-1h-benzimidazola | |
| FR2811229B1 (fr) | Utilisation d'un polysaccharide excrete par l'espece vibrio diabolicus en cicatrisation osseuse | |
| RU97117419A (ru) | Эндопротез голеностопного сустава | |
| DE60023034D1 (en) | Cd45 hemmer | |
| BG104258A (en) | 4-cyano-4-deformylsordarin derivatives | |
| MD980129A (en) | Antiherpetic remedy | |
| NO20016326L (no) | Anvendelse av proteinet UK 114 for å hindre avstötning av organtransplantatet | |
| of Man | An act (Chapter No. 3) to prohibit commercial dealings in human organs intended for transplanting; to prohibit the transplanting of such organs between persons who are not genetically related; and for connected purposes. Dated 16 March 1993.(The Human Organ Transplants Act 1993) |